Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
21.64
+0.08 (0.37%)
May 22, 2026, 4:00 PM EDT - Market closed
KMTS Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, KMTS stock has a consensus rating of "Strong Buy" and an average price target of $27.71. The average 1-year stock price forecast is 28.05% higher than the current stock price, while the lowest is $17 (-21.44%) and the highest is $30 (+38.63%).
Price Target: $27.71 (+28.05%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 9, 2026.
Analyst Ratings
The average analyst rating for KMTS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | -21.44% | Apr 9, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +47.87% | Apr 7, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +47.87% | Mar 25, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +47.87% | Mar 18, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $22 → $25 | Hold | Maintains | $22 → $25 | +15.53% | Dec 15, 2025 |
Financial Forecast
Revenue This Year
94.83M
from 59.82M
Increased by 58.54%
Revenue Next Year
94.83M
from 94.83M
Decreased by -0.00%
EPS This Year
-2.38
from -5.13
EPS Next Year
-2.40
from -2.38
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
| High | 97.8M | 97.8M | |||||
| Avg | 94.8M | 94.8M | |||||
| Low | 91.0M | 91.0M |
Revenue Growth
| Revenue Growth | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
| High | 63.4% | 3.1% | |||||
| Avg | 58.5% | -0.0% | |||||
| Low | 52.1% | -4.1% |
EPS Forecast
| EPS | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 |
|---|---|---|---|---|---|---|
| High | -2.42 | -2.42 | ||||
| Avg | -2.38 | -2.40 | ||||
| Low | -2.31 | -2.34 |
EPS Growth
| EPS Growth | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.